Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials-Reference-Cited by-同舟云学术

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials

Published:2019-04-01 Issue:4 Volume:76 Page:374
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Falk Daniel E.¹,O’Malley Stephanie S.²,Witkiewitz Katie³,Anton Raymond F.⁴,Litten Raye Z.¹,Slater Megan⁵,Kranzler Henry R.⁶,Mann Karl F.⁷,Hasin Deborah S.⁸⁹,Johnson Bankole¹⁰,Meulien Didier¹¹,Ryan Megan¹,Fertig Joanne¹,

Affiliation:

1. National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland

2. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

3. Department of Psychology, University of New Mexico, Albuquerque

4. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston

5. CSR, Incorporated

6. Department of Psychiatry, University of Pennsylvania, Philadelphia

7. Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany

8. Department of Psychiatry, Mailman School of Public Health, Columbia University, New York, New York

9. Department of Epidemiology, Columbia University, New York, New York

10. Department of Psychiatry, University of Maryland School of Medicine, Baltimore

11. CRD Neurology, Lundbeck SAS, Valby, Denmark

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

http:///jamapsychiatry/article-pdf/76/4/374/17420104/jamapsychiatry_falk_2019_oi_180078.pdf

Reference31 articles.

1. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions.;Grant;JAMA Psychiatry,2017

2. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III.;Grant;JAMA Psychiatry,2015

3. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.;Mark;Drug Alcohol Depend,2009

4. Discovery, development, and adoption of medications to treat alcohol use disorder: goals for the phases of medications development.;Litten;Alcohol Clin Exp Res,2016

5. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.;Cohen;Drug Alcohol Depend,2007

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication development for AUD: A systematic review of clinical trial methodology;Alcohol;2024-11

2. Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes;European Journal of Internal Medicine;2024-09

3. Examining cocaine use reductions and long-term outcomes in two clinical trials of continuing care for cocaine dependence;Journal of Substance Use and Addiction Treatment;2024-08

4. Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder;Pharmaceutical Medicine;2024-07

5. Novel medications for problematic alcohol use;Journal of Clinical Investigation;2024-06-03